Abstract
The underlying mechanisms of probiotics and postbiotics are not well understood, but it is known that both affect the adaptive and innate immune responses. In addition, there is a growing concept that some probiotic strains have common core mechanisms that provide certain health benefits. Here, we aimed to elucidate the signalization of the probiotic bacterial strains Lactobacillus paragasseri K7, Limosilactobacillus fermentum L930BB, Bifidobacterium animalis subsp. animalis IM386 and Lactiplantibacillus plantarum WCFS1. We showed in in vitro experiments that the tested probiotics exhibit common TLR2‐ and TLR10‐dependent downstream signalling cascades involving inhibition of NF‐κB signal transduction. Under inflammatory conditions, the probiotics activated phosphatidylinositol 3‐kinase (PI3K)/Akt anti‐apoptotic pathways and protein kinase C (PKC)‐dependent pathways, which led to regulation of the actin cytoskeleton and tight junctions. These pathways contribute to the regeneration of the intestinal epithelium and modulation of the mucosal immune system, which, together with the inhibition of canonical TLR signalling, promote general immune tolerance. With this study we identified shared probiotic mechanisms and were the first to pinpoint the role of anti‐inflammatory probiotic signalling through TLR10.
Keywords: Bifidobacterium, innate immunity, Lactobacillus, postbiotics, TLR10
Abbreviations
- Akt
protein kinase B
- APCs
antigen‐presenting cells
- IEC
intestinal epithelial cell
- IM386
Bifidobacterium animalis subsp. animalis IM386
- JAM
junction adhesion molecule
- K7
Lactobacillus paragasseri K7
- L930BB
Limosilactobacillus fermentum L930BB
- MAMP
microbe‐associated molecular patterns
- MAPK
mitogen‐activated protein kinase
- NF‐κB
nuclear factor kappa B
- PAM2
Pam2Cys‐SK4
- PAM3
Pam3Cys‐SK4
- PI3K
phosphatidylinositol 3‐kinase
- PKC
protein kinase C
- PKCinh
PKC inhibitor Gӧ6983
- PRRs
pattern recognition receptors
- TLR
Toll‐like receptor
- WCFS1
Lactiplantibacillus plantarum WCFS1
- ZO‐1
zonula occludens‐1
1. INTRODUCTION
The intestinal epithelial layer is composed of different cell types, which together form a physiological barrier where nutrient metabolism and absorption take place. In addition, epithelial cells are also an important first line of defence, as they are in constant interaction with bacteria and bacterial components on the apical surface and are in close proximity to immune cells on the basolateral side (Goto, 2019). The intestinal epithelium thus serves as a dynamic barrier that is regulated by the immune system through a complex combination of responses involving both innate and adaptive immunity (Allaire et al., 2018). Over the years, research studies have shown that gut microbiota has an important impact on intestinal homeostasis and the regulation of the intestinal epithelial barrier integrity. Perturbations in the composition and function of gut microbiota have been associated with chronic diseases ranging from irritable bowel disease and metabolic disorders to neurological, cardiovascular and respiratory conditions (Tlaskalová‐Hogenová et al., 2011). New preventive and therapeutic approaches now include changing the composition of the gut microbiota with prebiotics, probiotics, postbiotics, reconstituting the bacterial population by faecal transplantation or adding antimicrobial agents to the diet (Shen et al., 2018).
The impact of probiotics is not limited to living bacteria but also includes the regulation of cellular homeostasis by microbial DNA, soluble proteins, cell wall components and metabolites (Adams, 2010; Aguilar‐Toalá et al., 2018). These microbe‐associated molecular patterns (MAMP) are recognised by the family of innate immune pattern recognition receptors (PRRs), such as Toll‐like receptors (TLRs) (Abreu, 2010). TLR signalling influences innate and adaptive immune regulation, which promotes pathogen clearance on the one hand and host–microbe symbiosis on the other (Spiljar, Merkler, & Trajkovski, 2017). However, TLRs are not only expressed in immune cells, such as antigen‐presenting cells (APCs), but also in intestinal epithelial cells (IEC; Price et al., 2018). On the apical surface of IECs, TLR2 recognises microbial membrane structures such as lipoteichoic acid, peptidoglycan and lipopeptides and is therefore involved in the detection of probiotics, which upon recognition trigger mitogen‐activated protein kinase (MAPK), nuclear factor kappa B (NF‐κB) and phosphatidylinositol 3‐kinase (PI3K) signalling cascades (Jiménez‐Dalmaroni, Gerswhin, & Adamopoulos, 2016; Maier, Anderson, Altermann, & Roy, 2018). TLR2 forms heterodimers with TLR1 and TLR6; however, its signalling cascades are also associated with TLR10 (Guan et al., 2010; Jin et al., 2007; Kang et al., 2009). According to recent studies, TLR10 is a negative regulator of TLR signalling and differs from other TLRs in the absence of a classical downstream signalling cascade leading to transcriptional activation of NF‐κB and proinflammatory cytokine production (Oosting et al., 2014). By suppressing the conventional MAPK signalling pathways, TLR10 thus plays an important role in immune tolerance (Jiang, Li, Hess, Guan, & Tapping, 2016). Because of its inhibitory effect on TLR1/TLR2 and TLR2/TLR6 signalling, TLR10 can regulate the immune response to a broad spectrum of microbial antigens.
Due to the difficulties in approving probiotic efficacy in clinical trials, current research is more focused on identifying probiotic mechanisms and host cell signalling pathways. Despite intensive research, the mechanisms behind cell signalling are not yet well understood. Our previous study on DSS‐induced colitic mouse model shows that a combination of two probiotic strains helped in the regeneration of the intestinal epithelium during pathogenesis via pathways that are known downstream targets of TLR2 (Paveljšek et al., 2018). In the present study, we aimed to reveal the TLR2‐mediated signalling pathways that are probably responsible for the regulation of the intestinal epithelial barrier. By using different in vitro setups of IECs challenged with probiotics, we investigated these signalling cascades triggered by four probiotic strains Lactobacillus paragasseri K7 isolated from the faeces of a 7‐day‐old infant (Treven, Trmčić, Matijašić, & Rogelj, 2014), Limosilactobacillus fermentum L930BB and Bifidobacterium animalis subsp. animalis IM386 isolated from the human intestinal mucosa (Čitar et al., 2015; Paveljšek et al., 2018), and Lactiplantibacillus plantarum WCFS1, human saliva isolate (Karczewski et al., 2010; Zheng et al., 2020). Our study confirmed former research findings that showed that activation of TLRs by commensal microorganisms is crucial for protection against intestinal damage (Bach, 2018). In addition, it also opened a new direction in mechanistic studies on the maintenance of intestinal homeostasis by probiotics.
2. RESULTS
2.1. Signalling of probiotic bacterial strains via TLR2‐NF‐κB
We used a dual luciferase reporter assay in the HEK293 cell line, transfected with TLRs and stimulated with the probiotic strains L. paragasseri K7 (K7), L. fermentum L930BB (L930BB), B. animalis subsp. animalis IM386 (IM386) and L. plantarum WCFS1 (WCFS1) at different concentrations. We found that all used probiotic strains activate the transcription factor NF‐κB through TLR1/TLR2 and through TLR2/TLR6 (Figure 1). IM386 triggered the highest activation of NF‐κB compared to other strains. The probiotic activation of NF‐κB through TLR2/TLR6 was higher than activation through TLR1/TLR2. Since TLR2 recognises lipoproteins, usually components of the bacterial surface, we were interested in whether the supernatant of bacterial growth medium and heat‐killed bacteria also trigger NF‐κB signalling cascades. We discovered that supernatant and heat‐killed bacteria trigger NF‐κB activation through TLR2 heterodimers in a similar concentration‐dependent manner as live bacteria. However, in the case of the heat‐killed strain WCFS1 and its supernatant, the activation of NF‐κB was lower compared to the activation with live bacteria (Figure S1). To determine the components that trigger the activation of NF‐κB, we further fractionated the supernatant with 10 kDa filters. We found that the components, responsible for TLR2‐induced NF‐κB activation, have a molecular weight of more than 10 kDa (Figure 2).
2.2. Probiotic inhibition of conventional TLR‐NF‐κB signalling pathway via TLR10 and stimulation of anti‐apoptotic pathways
To test how probiotic strains affect TLR10 signalling cascades, we performed a dual luciferase reporter assay in the HEK293 cell line with expressed TLR1/TLR2, TLR2/TLR6 and increasing levels of expressed TLR10. We discovered that probiotic strains reduced the activation of NF‐κB in the presence of TLR10 via both TLR1/TLR2 and TLR2/TLR6 (Figure 3). To test the possible involvement of PI3K/Akt pathway in the inhibitory effect of TLR10, we used a non‐overexpression system on the IEC line Caco‐2. After addition of probiotic strains, phosphorylation of Akt, which is a measure of its activation by PI3K, was observed. In addition, the use of TLR2 and PI3K inhibitors reduced phosphorylation of Akt (Figure 4).
Since one of the most important signalling cascades via PI3K/Akt leads to the inhibition of apoptotic pathways, we tested whether the selected probiotic strains can influence cytokine‐induced apoptosis and necrosis. We used the IEC line HT‐29, which also expresses surface TLRs and shows a better inflammatory response to cytokines than the Caco‐2 cell line. The extent of apoptosis and necrosis was determined by analysing the live/dead HT‐29 cell populations with flow cytometry. The addition of probiotic strains to HT‐29 cell line reduced necrosis and late apoptosis caused by the addition of inflammatory cytokines (Figures 5 and S2). Furthermore, the TLR2 synthetic ligands and the probiotic strains had a similar protective effect on cell necrosis, proving TLR2‐mediated mechanism.
2.3. Probiotic impact on the intestinal epithelial barrier
We first investigated the possible protective effect of probiotic strains on the permeability of the H2O2‐disrupted Caco‐2 cell monolayer. We monitored the transition of FITC‐dextran from the apical to the basolateral compartment of semi‐permeable membranes. The addition of selected probiotic strains and the synthetic TLR2 ligand—Pam3Cys‐SK4 (PAM3) to the Caco‐2 cell line cultured on permeable supports did not alter the cell monolayer permeability (Figure 6). However, their addition to the H2O2‐disrupted Caco‐2 cells led to a reduction in permeability. Given that probiotics had the same protective effect as PAM3, we next investigated whether the probiotic influence on epithelial permeability is related to the PKC signalling pathway, a known TLR2‐dependent pathway that impacts on the paracellular sealing complex. We found that the addition of PKC inhibitor Gӧ6983 (PKCinh) reduced the protective effect of the probiotic strains, which verifies the relationship between probiotic activity and the PKC signalling pathway. In fact, permeability increased to the level of the cell monolayer exposed only to oxidative stress with H2O2 (Figure 6). However, the potency of inhibition was weaker for WCFS1.
Since TLR2 signalling cascades can influence the PKC‐mediated distribution of tight junctions (Figure S3), we investigated whether probiotic signalling through PKC is involved in this regulation as well. The localization of the fluorescently labelled cytoplasmic tight junction protein zonula occludens‐1 (ZO‐1) was examined by confocal microscopy in the Caco‐2 cell line. The addition of H2O2 caused the ZO‐1 protein to migrate away from the membrane site into the cell interior, where it no longer connects other transmembrane tight junctions with the actin cytoskeleton (Figure 7). This was observed as punctate staining in cytoplasm and as spacing/ring‐like staining pattern adjacent to the cell–cell interface. Irregular undulating patterns of ZO‐1 were also visible on the cell periphery. The preventive addition of the probiotic strains K7, L930BB, IM386 and WCFS1 reduced the H2O2‐induced intercellular spacing and internalisation of ZO‐1 and the addition of PKCinh prevented the protective effect of the probiotic strains (Figures 7, S4 and S5).
3. DISCUSSION
Beneficial effects of probiotic bacteria are often defined by the impact on the host gut microbiota, by the regulation of intestinal epithelial barrier function and the regulation of the immune response (Bermudez‐Brito, Plaza‐Díaz, Muñoz‐Quezada, Gómez‐Llorente, & Gil, 2012). Cell lines as model systems are used in a variety of research studies dealing with the protective effects of probiotics, ranging from studies of cell signal transduction to the administration of drugs and processes of intestinal diseases. Although they only approximate the properties of in vivo cells in tissues (Engle, Goetz, & Alpers, 1998 ), these models also offer advantages, including more controlled conditions and robustness. However, for more thorough conclusions, it is still necessary to start from more complex models that better reflect the native state. Therefore, we have based our study on the mouse experiment from our previous publication. In a previous study, we performed a global gene expression analysis in a DSS‐induced mouse model of colitis and emphasised that the beneficial probiotic effect was probably associated with TLR2 downstream signalization (Paveljšek et al., 2018). Now, we mainly focused on the probiotic modulation of innate immune signalling and the intestinal epithelial barrier maintenance. We investigated the protective effect of probiotics in inflammatory conditions by determining cell viability and cell monolayer permeability and observing the distribution of tight junction protein ZO‐1 and actin cytoskeleton. We discovered that the selected bacterial strains have a similar effect on the potential TLR2 signalling at the intestinal epithelial interface and elicit three probiotic properties: (a) general tolerance and immune regulation via TLR10, (b) cell survival and reduced necrosis via PI3K/Akt pathway and (c) improved barrier integrity via PKC and ZO pathway (Figure 8).
Besides the poorly understood biological function of TLR10, which in contrast to other TLRs mainly has an inhibitory effect, there are also no known ligands for this receptor (Jiang et al., 2016). We showed that the co‐expression of TLR10 with TLR1/TLR2 as well as with TLR2/TLR6 had an inhibitory effect on NF‐κB‐mediated response to probiotics, which has not been shown in the literature before. The signalling of probiotic strains through TLR10 may therefore be considered as an additional immune‐regulatory effect that promotes remission in autoimmune intestinal diseases. In addition, the TLR2 signalling cascades of live bacteria were similar to those of the heat‐killed and cell‐free supernatant. Showing, that the metabolites and/or cell wall components released by probiotics, defined by the term postbiotics, represent an important component of innate immune regulation. These signalling cascades, possibly triggered by the TLR2‐TLR10 assembly, include the PI3K/Akt anti‐apoptotic pathway that inhibits MAPKs/NF‐κB signal transduction, thereby providing general tolerance to commensals on the mucosal barrier.
In IECs, the absence of TLR2 causes inadequate PI3K/Akt signalling and disruption of the intracellular anchoring complex. This leads to increased apoptosis, detachment of colonocytes and consequently to a greater permeability of the epithelial barrier, resulting in mucosal inflammation (Cario, Gerken, & Podolsky, 2007). Indeed, we showed that probiotics induce signalling through PI3K/Akt and reduce necrosis in inflammatory conditions and thereby help to maintain the barrier integrity.
We also examined the probiotic influence in stress conditions on activation of PKC—another TLR2‐mediated downstream signalling pathway that can prevent internalisation or translocation of the cytosolic tight junction protein ZO‐1 from the plasma membrane and is also important for the epithelial barrier integrity (Corr et al., 2014; Gu et al., 2016). IECs express a number of PKCs that regulate the phosphorylation state and localization of several tight junction proteins (Zyrek et al., 2007). According to Cario, Gerken, and Podolsky (2004), stimulation of the TLR2 pathway leads to activation of PKCα and PKCδ, and subsequently to redistribution of ZO‐1 and improvement of cell monolayer integrity. In our study, both probiotic strains and TLR2 ligands triggered the activation of specific PKC isoforms, which had an influence on the localization of ZO‐1 and consequently on the reduction of cell monolayer permeability, suggesting and confirming that TLR2 signalization is responsible for this downstream effect.
Interestingly, the same mechanism of action and the same TLR2 signalling cascades were observed for all selected probiotics. This can be explained by the fact that the MAMPs that trigger signalization have a similar basic structure and are conserved among a larger group of probiotics (Sanders, Benson, Lebeer, Merenstein, & Klaenhammer, 2018). It is also important to keep in mind that the bacterial cell surface is a dynamic property and the expression of bacterial surface components may vary due to the host environment (Lebeer, Vanderleyden, & De Keersmaecker, 2010). Furthermore, recent research demonstrates that some of the molecular complexes responsible for immuno‐modulation in host cells may be common to a larger taxonomic group (Lebeer et al., 2018), which additionally contributes to the shared probiotic properties, also considering that TLR2 recognises a broad spectrum of ligands (Jiménez‐Dalmaroni et al., 2016). Besides, selected probiotic strains also showed no NF‐κB activity via TLR5 and TLR9 (Figure S6), thus excluding other TLR signalling, since lactic acid bacteria and bifidobacteria do not possess LPS (TLR4 signalization) and the remaining TLRs are associated mainly with viral infections. Certainly, some important mechanisms are only present in a few probiotic strains, but some molecules are not strain‐specific and have homologues among different strains or even other species. For example, the secretory proteins p40 and p75 derived from Lacticaseibacillus rhamnosus GG have homologues in the genomes of L. casei, L. paracasei and L. rhamnosus (Bäuerl, Pérez‐Martínez, Yan, Polk, & Monedero, 2011). However, the fact that the heat‐killed WCFS1 did not elicit the same NF‐κB activity as live culture, brings up the question whether the ligands for TLR2 of WCFS1 are structurally different and heat sensitive compared to the other three probiotic strains.
In addition to the nature of ligand, the activation of specific signalling pathways and the outcome of MAMP–PRR interactions also depend on the type of host cell and the use of different cell lines (Gagnon, Zihler Berner, Chervet, Chassard, & Lacroix, 2013). Variances in the downstream signalling cascades occur when we compare the response of immune cells and of IECs, which are polarised and have lower expression of surface PRRs (Price et al., 2018). For example, TLR2 signalling via the MyD88 pathway in IECs usually has a protective effect by promoting immune tolerance to microbiota. In contrast, the TLR signalling of immune cells has an inflammatory response to bacterial ligands, which helps to prevent bacterial invasion through the epithelial monolayer (Abreu, 2010; Goto, 2019; Yu & Gao, 2015).
We would also like to point out the limitations of this type of studies, where it is sometimes difficult to draw conclusions with experiments on cell models only, as these do not cover the effects on the overall regulation of the immune system. It is also difficult to compare the results of different studies where different protocols as well as different cell lines are used. Furthermore, cell lines only represent an approximation of the real biological state, so it is essential that these studies are supported by more complex models such as organoids or experiments on animal models, which were also the starting point of our study (Paveljšek et al., 2018).
In conclusion, we were able to show that the strains L930BB, IM386, K7 and WCFS1 induce the TLR2 signalling, activate anti‐apoptotic pathways, impact on tight junction proteins and the actin cytoskeleton and thus contribute to the regeneration of the intestinal epithelium and the modulation of the mucosal barrier of the immune system. The results of our study confirmed and connected important observations from other studies and are a step forward in understanding probiotic communication with host cells and its beneficial effects.
4. EXPERIMENTAL PROCEDURES
4.1. Cell lines and bacterial strains
Human embryonic kidney cell line HEK293 (ATCC CRL‐1573), human colon adenocarcinoma cell line Caco‐2 (ATCC HTB‐37) and human colon adenocarcinoma cell line HT‐29 (ATCC HTB‐38) were cultured in complete media [Dulbecco's Modified Eagle Medium (for HEK293 and Caco‐2) or McCoy 5a (for HT‐29), 10% heat‐inactivated foetal bovine serum (FBS, Gibco, Invitrogen)] in 5% CO2 at 37°C. Media for HT‐29 and Caco‐2 cell lines also included 1% penicillin–streptomycin (Thermo Fisher Scientific) which was excluded from the media 2 days prior to the experiments. Cell viability was determined prior plate seeding by counting trypan blue‐stained samples using the Countess instrument (Thermo Fisher Scientific). The survival values were above 90% in all experiments.
Limosilactobacillus fermentum L930BB (DSMZ 26139) and B. animalis subsp. animalis IM386 (DSMZ 26137) strains were obtained from bioptic samples of colonic mucosa and deposited in a culture collection at the Biotechnical faculty, University of Ljubljana and in the Leibniz‐Institut—DSMZ. Lactobacillus paragasseri K7 strain was obtained from infant faeces and deposited in a culture collection at the Biotechnical faculty, University of Ljubljana and in the Czech Collection of Microorganisms under accession number CCM7710. Lactiplantibacillus plantarum WCFS1 strain is deposited in the Laboratorium voor Microbiologie, Universiteit Gent under accession number LMG9211. All bacterial strains were cultured at 37°C in De Man, Rogosa, and Sharpe (MRS) broth (Merck). For the stimulation experiments, overnight bacterial cultures were centrifuged (10 min, 8000 rcf), pellet was washed with PBS, centrifuged and resuspended in DMEM with 10% FBS. After described preparation, bacterial cell concentration was adjusted by measuring the optical density at 650 nm. When cell‐free supernatant was used for stimulation of HEK293 cell line, bacterial strains were cultured in DMEM. Cell‐free supernatant was prepared with centrifugation of overnight culture (10 min, 8000 rcf) and sterile filtration through 0.2 μm filter (Merck). In additional experiments, cell‐free supernatant was concentrated with 10 kDa cut‐off filter device Amicon (Merck) for 20 min at 3850 rcf. Heat‐killed bacterial cells were treated for 30 min at 80°C.
4.2. Dual luciferase reporter assay
HEK293 cells were seeded in 96‐well plates (Corning) at 2.7 × 104 cells per well. Cells reached 50% confluence overnight and were at that point transiently transfected with different combinations of pUNO plasmids expressing TLR1, TLR2, TLR6 (5 ng DNA per well), TLR10 (5–60 ng DNA per well) or pcDNA3 (Invivogen), ELAM1‐luciferase reporter plasmid (50 ng DNA per well) (Kirschning, University of Duisburg‐Essen, Germany), and phRL‐TK (5 ng DNA per well, Promega) using the jetPEI transfection reagent (Polyplus Transfection). The plasmids pUNO‐hTLR5 (10 ng DNA per well) to verify signalling via TLR5 and pUNO‐hTLR9 (20 ng DNA per well) with pUNO1‐hUNC93B1 (5 ng DNA per well) to verify signalling via TLR9 were used by the same transfection protocol. After 24 hr, the culture medium was replaced with fresh medium, and the cells were stimulated with probiotic strains or TLR2 agonists (InvivoGen), Pam3Cys‐SK4 (PAM3) (50 ng/mL) or Pam2Cys‐SK4 (PAM2) (5 ng/mL), for 18 hr. In case of TLR5 signalization the ligand S. typhimurium flagellin (SaTy) (50 ng/mL) was used and in case of TLR9 signalization the ligand CpG‐ODN 2006 Biotin (10 μM) was used. The cells were lysed in passive lysis buffer (Promega) and analysed for reporter gene activities using a dual luciferase reporter assay. The Renilla luciferase reporter (phRL‐TK) was used as an internal control for normalisation. Standard deviation was calculated from four replicates. The experiment was performed in three biological replicates.
4.3. Western blot
Caco‐2 cells (24th–26th passage) were seeded in a 6‐well plate (Corning) at a density of 3.3 × 105 cells per well and cultured for 10 days until complete confluency with media changes every other day. Two days before the experiment antibiotic‐free media with 200 μM LY294002 (LY, Invivogen) or 5 μg/mL PAb hTLR2 (abTLR2, Invivogen) was added to the designated test wells. One hour before the experiment, the media with inhibitors was changed again. Cells were stimulated for 1 hr with probiotic strains (107 CFU per well) or TLR2 ligands, PAM2 (2 μg/mL) or PAM3 (20 μg/mL). After stimulation, the cells were washed twice with cold PBS and lysed on ice for 30 min in 170 μL of RIPA buffer (Thermo Fisher Scientific) containing 1:100 protease inhibitors (Thermo Fisher Scientific) and 1:5 phosphatase inhibitors (Merck Millipore). Cell debris was removed by centrifugation at 13400 rpm, 4°C for 30 min. The total protein concentration in the supernatant was determined using the BCA assay. Further, proteins from the supernatant were separated by SDS‐PAGE and transferred to a Hybond ECL nitrocellulose membrane (GE Healthcare). The membrane was incubated in blocking buffer [1 × PBS, 0.1% Tween 20, 0.2% I‐Block (Tropix)] overnight at 4°C. The membranes were incubated with primary antibodies diluted in blocking buffer for 90 min, washed (1× PBS, 0.1% Tween 20), and incubated with secondary antibodies for 45 min at room temperature. Secondary antibodies were detected with the ECL Western blotting detection reagent (GE Healthcare), according to the manufacturer's protocol. The primary antibodies were rabbit Phospho‐Akt Thr308 (pAkt) (9275S, Cell Signaling Technology) and mouse β‐aktin 8H10D10 (3700, Cell Signaling Technology) diluted 1:1000. Secondary antibodies were HRP‐conjugated goat anti‐rabbit IgG (ab6721, Abcam) and HRP‐conjugated goat anti‐mouse IgG (sc‐2005, Santa Cruz) diluted 1:5000. The experiment was performed in three biological replicates.
4.4. Flow cytometry
HT‐29 cells (16th passage) were 5seeded in a 24‐well plate (Corning) at a density of 5 × 105 cells per well. Media was changed daily, and cells were cultured for 3–4 days under standard culture conditions until complete confluency. Cells were stimulated for 1 hr with probiotic strains (107 CFU per well) or PAM3 (2 μg/mL). After stimulation, the media was removed and cells were treated for 5 hr with cytokines (100 ng/mL TNF‐α, 100 ng/mL IFN‐γ, 10 ng/mL IL‐1β). Control for apoptosis were camptothecin‐treated cells (CPT, 60 μM) and control for necrosis were heat‐treated cells (20 min, 60°C). After the treatment, the cells were trypsinised and media was removed. The cells were stained according to the manufacturer's instructions with Annexin V Apoptosis Detection Kit eFluor 450 (eBioscience) and analysed within 4 hr on flow cytometer (CyFlow space, Partec). Data was analysed with FlowJo software (Tree Star). The experiment was performed in two biological replicates.
4.5. Fluorometric analysis of cell monolayer permeability
Caco‐2 cells (26th passage) were seeded on 12‐well semi‐permeable membranes (Transwell, Corning) at a density of 7 × 104 cells per well and cultured for 21 days until differentiation with media changes every other day. The designated group of cells was treated with PKC inhibitor Gӧ6983 (PKCinh) (5 μg/mL, Sigma) 1 hr before the experiment. Afterwards, the probiotic strains (107 CFU per well) or PAM3 (20 μg/mL) were added to the apical compartment and incubated for 1 hr. After incubation H2O2 (750 μM) was added to both compartments and 3 kDa FITC‐dextran (0.2 mg/mL, Thermo Fisher Scientific) was added to the apical compartment. Samples were taken from the basolateral compartment and the fluorescence intensity was measured on a Synergy MX microtiter plate reader (Tecan). The experiment was performed in two biological replicates. Statistical analysis was carried out using unpaired Student's t test. A p‐value of ≤.05 and ≤.01 was considered statistically significant.
4.6. Confocal microscopy
Caco‐2 cells were seeded onto eight‐well tissue culture chambers (Ibidi) at a density of 1.78 × 104 cells per well and cultured for 21 days with media changes every other day. The designated group of cells was treated with PKCinh (20 μM, Sigma) 1 hr before the experiment. Subsequently, the cells were stimulated for 1 hr with probiotic strains (107 CFU per well) or PAM3 (20 μg/mL). After the stimulation, the media was removed, and the cells were washed with PBS. Fresh media with 100 μM H2O2 was added for 2 hr. Cells were washed again with PBS, fixed (4% paraformaldehyde) and permeabilised (0.1% Triton‐x100, Sigma). The cells were stained for F‐actin, ZO‐1 and nucleus with Phalloidin Alexa Fluor 647 (8940, Cell Signaling Technology), ZO‐1 Alexa Fluor 488 (ZO1‐1A12, Thermo Fisher Scientific) and DAPI (D21490, Thermo Fisher Scientific). Images were acquired using the Leica TCS SP5 confocal microscope equipped with an HCX Plan‐Apochromat lambda blue ×63 oil‐immersion objective with NA 1.4 (Leica Microsystems). The images were processed with LAS AF software (Leica Microsystems). The experiment was performed in three biological replicates.
CONFLICT OF INTEREST
The authors declare no conflicts of interest.
AUTHOR CONTRIBUTIONS
Diana Paveljšek, Mojca Benčina and Karolina Ivičak‐Kocjan performed the experiments and analysed the data. Roman Jerala and Irena Rogelj conceived the experiments. Diana Paveljšek and Primož Treven wrote the manuscript with input from the other authors.
Supporting information
ACKNOWLEDGEMENTS
This work was funded by a Young Researcher Program from the Slovenian Research Agency (Contract No. 1000‐16‐0510, D. P.—36376).
Paveljšek D, Ivičak‐Kocjan K, Treven P, Benčina M, Jerala R, Rogelj I. Distinctive probiotic features share common TLR2‐dependent signalling in intestinal epithelial cells. Cellular Microbiology. 2021;23:e13264 10.1111/cmi.13264
Funding information Javna Agencija za Raziskovalno Dejavnost RS, Grant/Award Number: 1000‐16‐0510
DATA AVAILABILITY STATEMENT
Additional data available on request from the authors.
REFERENCES
- Abreu, M. T. (2010). Toll‐like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nature Reviews Immunology, 10(2), 131–143. 10.1038/nri2707 [DOI] [PubMed] [Google Scholar]
- Adams, C. A. (2010). The probiotic paradox: Live and dead cells are biological response modifiers. Nutrition Research Reviews, 23(1), 37–46. 10.1017/S0954422410000090 [DOI] [PubMed] [Google Scholar]
- Aguilar‐Toalá, J. E. , Garcia‐Varela, R. , Garcia, H. S. , Mata‐Haro, V. , González‐Córdova, A. F. , Vallejo‐Cordoba, B. , & Hernández‐Mendoza, A. (2018). Postbiotics: An evolving term within the functional foods field. Trends in Food Science & Technology, 75, 105–114. 10.1016/j.tifs.2018.03.009 [DOI] [Google Scholar]
- Allaire, J. M. , Crowley, S. M. , Law, H. T. , Chang, S. , Ko, H. , & Vallance, B. A. (2018). The intestinal epithelium: Central coordinator of mucosal immunity. Trends in Immunology, 39(9), 677–696. 10.1016/j.it.2018.04.002 [DOI] [PubMed] [Google Scholar]
- Bach, J.‐F. (2018). The hygiene hypothesis in autoimmunity: The role of pathogens and commensals. Nature Reviews Immunology, 18, 105–120. 10.1038/nri.2017.111 [DOI] [PubMed] [Google Scholar]
- Bäuerl, C. , Pérez‐Martínez, G. , Yan, F. , Polk, D. B. , & Monedero, V. (2011). Functional analysis of the p40 and p75 proteins from Lactobacillus casei BL23. Journal of Molecular Microbiology and Biotechnology, 19(4), 231–241. 10.1159/000322233 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bermudez‐Brito, M. , Plaza‐Díaz, J. , Muñoz‐Quezada, S. , Gómez‐Llorente, C. , & Gil, A. (2012). Probiotic mechanisms of action. Annals of Nutrition and Metabolism, 61(2), 160–174. 10.1159/000342079 [DOI] [PubMed] [Google Scholar]
- Cario, E. , Gerken, G. , & Podolsky, D. K. (2004). Toll‐like receptor 2 enhances ZO‐1‐associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology, 127(1), 224–238. 10.1053/j.gastro.2004.04.015 [DOI] [PubMed] [Google Scholar]
- Cario, E. , Gerken, G. , & Podolsky, D. K. (2007). Toll‐like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology, 132(4), 1359–1374. 10.1053/j.gastro.2007.02.056 [DOI] [PubMed] [Google Scholar]
- Čitar, M. , Hacin, B. , Tompa, G. , Štempelj, M. , Rogelj, I. , Dolinšek, J. , … Bogovic Matijašić, B. (2015). Human intestinal mucosa‐associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL‐10, IL‐6 and IL‐12 gene expression in THP‐1 cells. Beneficial Microbes, 6(3), 325–336. 10.3920/BM2014.0081 [DOI] [PubMed] [Google Scholar]
- Corr, S. C. , Palsson‐McDermott, E. M. , Grishina, I. , Barry, S. P. , Aviello, G. , Bernard, N. J. , … O'Neill, L. A. J. (2014). MyD88 adaptor‐like (Mal) functions in the epithelial barrier and contributes to intestinal integrity via protein kinase C. Mucosal Immunology, 7(1), 57–67. 10.1038/mi.2013.24 [DOI] [PubMed] [Google Scholar]
- Engle, M. J. , Goetz, G. S. , & Alpers, D. H. (1998). Caco‐2 cells express a combination of colonocyte and enterocyte phenotypes. Journal of Cellular Physiology, 174(3), 362–369. [DOI] [PubMed] [Google Scholar]
- Gagnon, M. , Zihler Berner, A. , Chervet, N. , Chassard, C. , & Lacroix, C. (2013). Comparison of the Caco‐2, HT‐29 and the mucus‐secreting HT29‐MTX intestinal cell models to investigate Salmonella adhesion and invasion. Journal of Microbiological Methods, 94(3), 274–279. 10.1016/j.mimet.2013.06.027 [DOI] [PubMed] [Google Scholar]
- Goto, Y. (2019). Epithelial cells as a transmitter of signals from commensal bacteria and host immune cells. Frontiers in Immunology, 10, 2057 10.3389/fimmu.2019.02057 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gu, M. J. , Song, S. K. , Lee, I. K. , Ko, S. , Han, S. E. , Bae, S. , … Yun, C.‐H. (2016). Barrier protection via Toll‐like receptor 2 signaling in porcine intestinal epithelial cells damaged by deoxynivalnol. Veterinary Research, 47, 25 10.1186/s13567-016-0309-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guan, Y. , Ranoa, D. R. E. , Jiang, S. , Mutha, S. K. , Li, X. , Baudry, J. , & Tapping, R. I. (2010). Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. The Journal of Immunology, 184(9), 5094–5103. 10.4049/jimmunol.0901888 [DOI] [PubMed] [Google Scholar]
- Jiang, S. , Li, X. , Hess, N. J. , Guan, Y. , & Tapping, R. I. (2016). TLR10 is a negative regulator of both MyD88‐dependent and ‐independent TLR signaling. The Journal of Immunology, 196(9), 3834–3841. 10.4049/jimmunol.1502599 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jiménez‐Dalmaroni, M. J. , Gerswhin, M. E. , & Adamopoulos, I. E. (2016). The critical role of Toll‐like receptors – From microbial recognition to autoimmunity: A comprehensive review. Autoimmunity Reviews, 15(1), 1–8. 10.1016/j.autrev.2015.08.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jin, M. S. , Kim, S. E. , Heo, J. Y. , Lee, M. E. , Kim, H. M. , Paik, S.‐G. , … Lee, J.‐O. (2007). Crystal structure of the TLR1‐TLR2 heterodimer induced by binding of a tri‐acylated lipopeptide. Cell, 130(6), 1071–1082. 10.1016/j.cell.2007.09.008 [DOI] [PubMed] [Google Scholar]
- Kang, J. Y. , Nan, X. , Jin, M. S. , Youn, S. , Ryu, Y. H. , Mah, S. , … Lee, J. (2009). Recognition of lipopeptide patterns by Toll‐like receptor 2‐toll‐like receptor 6 heterodimer. Immunity, 31(6), 873–884. 10.1016/j.immuni.2009.09.018 [DOI] [PubMed] [Google Scholar]
- Karczewski, J. , Troost, F. J. , Konings, I. , Dekker, J. , Kleerebezem, M. , Brummer, R. M. , & Wells, J. M. (2010). Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. American Journal of Physiology Gastrointestinal and Liver Physiology, 298, 851–859. 10.1152/ajpgi.00327.2009 [DOI] [PubMed] [Google Scholar]
- Lebeer, S. , Bron, P. A. , Marco, M. L. , Motherway, M. O. C. , Hill, C. , Pot, B. , … Klaenhammer, T. (2018). Identification of probiotic effector molecules: Present state and future perspectives. Current Opinion in Biotechnology, 49, 217–223. 10.1016/j.copbio.2017.10.007 [DOI] [PubMed] [Google Scholar]
- Lebeer, S. , Vanderleyden, J. , & De Keersmaecker, S. C. J. (2010). Host interactions of probiotic bacterial surface molecules: Comparison with commensals and pathogens. Nature Reviews Microbiology, 8(3), 171–184. 10.1038/nrmicro2297 [DOI] [PubMed] [Google Scholar]
- Maier, E. , Anderson, R. C. , Altermann, E. , & Roy, N. C. (2018). Live Faecalibacterium prausnitzii induces greater TLR2 and TLR2/6 activation than the dead bacterium in an apical anaerobic co‐culture system. Cellular Microbiology. 20(2), 1–11. 10.1111/cmi.12805 [DOI] [PubMed] [Google Scholar]
- Oosting, M. , Cheng, S.‐C. , Bolscher, J. M. , Vestering‐Stenger, R. , Plantinga, T. S. , Verschueren, I. C. , … Joosten, L. A. B. (2014). Human TLR10 is an anti‐inflammatory pattern‐recognition receptor. Proceedings of the National Academy of Sciences, 111(42), E4478–E4484. 10.1073/pnas.1410293111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paveljšek, D. , Juvan, P. , Košir, R. , Rozman, D. , Hacin, B. , Ivicak‐Kocjan, K. , & Rogelj, I. (2018). Lactobacillus fermentum L930BB and Bifidobacterium animalis subsp. animalis IM386 initiate signalling pathways involved in intestinal epithelial barrier protection. Beneficial Microbes, 9(3), 515–525. 10.3920/BM2017.0107 [DOI] [PubMed] [Google Scholar]
- Price, A. E. , Shamardani, K. , Lugo, K. A. , Deguine, J. , Roberts, A. W. , Lee, B. L. , & Barton, G. M. (2018). A map of Toll‐like receptor expression in the intestinal epithelium reveals distinct spatial, cell type‐specific, and temporal patterns. Immunity, 49(3), 560–575.e6. 10.1016/j.immuni.2018.07.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanders, M. E. , Benson, A. , Lebeer, S. , Merenstein, D. J. , & Klaenhammer, T. R. (2018). Shared mechanisms among probiotic taxa: Implications for general probiotic claims. Current Opinion in Biotechnology, 49, 207–216. 10.1016/j.copbio.2017.09.007 [DOI] [PubMed] [Google Scholar]
- Shen, Z. , Zhu, C. , Quan, Y. , Yang, Z. , Wu, S. , Luo, W. , … Wang, X. (2018). Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation. World Journal of Gastroenterology, 24(1), 5–14. 10.3748/wjg.v24.i1.5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spiljar, M. , Merkler, D. , & Trajkovski, M. (2017). The immune system bridges the gut microbiota with systemic energy homeostasis: Focus on TLRs, mucosal barrier, and SCFAs. Frontiers in Cellular and Infection Microbiology, 8, 1353 10.3389/fimmu.2017.01353 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tlaskalová‐Hogenová, H. , Štěpánková, R. , Kozáková, H. , Hudcovic, T. , Vannucci, L. , Tučková, L. , … Funda, D. P. (2011). The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: Contribution of germ‐free and gnotobiotic animal models of human diseases. Cellular & Molecular Immunology, 8, 110–120. 10.1038/cmi.2010.67 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Treven, P. , Trmčić, A. , Matijašić, B. B. , & Rogelj, I. (2014). Improved draft genome sequence of probiotic strain Lactobacillus gasseri K7. Genome Announcements, 2(4), 6–7. 10.1128/genomeA.00725-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yu, S. , & Gao, N. (2015). Compartmentalizing intestinal epithelial cell Toll‐like receptors for immune surveillance. Cellular and Molecular Life Sciences, 72(17), 3343–3353. 10.1007/s00018-015-1931-1.Compartmentalizing [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zheng, J. , Wittouck, S. , Salvetti, E. , Franz, C. M. A. B. , Harris, H. M. B. , Mattarelli, P. , … Lebeer, S. (2020). A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae . International Journal of Systematic and Evolutionary Microbiology, 70, 2782–2858. 10.1099/ijsem.0.004107 [DOI] [PubMed] [Google Scholar]
- Zyrek, A. A. , Cichon, C. , Helms, S. , Enders, C. , Sonnenborn, U. , & Schmidt, M. A. (2007). Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO‐2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair. Cellular Microbiology, 9, 804–816. 10.1111/j.1462-5822.2006.00836.x [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Additional data available on request from the authors.